<?xml version="1.0" encoding="UTF-8"?>
<p id="Par65">The business case for funding prevention and treatment of viral hepatitis needs to be fully researched, developed and strongly made. Potential traditional funders and new funding mechanisms need to be vigorously and thoroughly investigated and persuaded to support prevention and control plans.</p>
